ProShare Advisors LLC purchased a new position in shares of TriMas Co. (NASDAQ:TRS – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,435 shares of the industrial products company’s stock, valued at approximately $281,000.
Several other institutional investors have also bought and sold shares of the stock. Bank of America Corp DE grew its stake in TriMas by 127.3% in the 4th quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company’s stock valued at $86,400,000 after purchasing an additional 1,967,738 shares during the period. Bellecapital International Ltd. bought a new position in TriMas in the 4th quarter valued at $29,160,000. Raymond James Financial Inc. bought a new position in TriMas in the 4th quarter valued at $6,698,000. Kennedy Capital Management LLC grew its stake in TriMas by 94.8% in the 4th quarter. Kennedy Capital Management LLC now owns 485,721 shares of the industrial products company’s stock valued at $11,944,000 after purchasing an additional 236,346 shares during the period. Finally, Advisory Research Inc. grew its stake in TriMas by 41.2% in the 4th quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company’s stock valued at $18,543,000 after purchasing an additional 220,000 shares during the period. Institutional investors own 99.42% of the company’s stock.
Insider Buying and Selling at TriMas
In other TriMas news, Director Shawn Sedaghat purchased 249,597 shares of the stock in a transaction on Friday, March 7th. The shares were purchased at an average price of $23.83 per share, with a total value of $5,947,896.51. Following the acquisition, the director now directly owns 346,825 shares in the company, valued at approximately $8,264,839.75. The trade was a 256.71% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Scott A. Mell sold 2,218 shares of the firm’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $22.54, for a total value of $49,993.72. Following the completion of the sale, the chief financial officer now directly owns 26,288 shares in the company, valued at approximately $592,531.52. The trade was a 7.78% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired a total of 1,770,195 shares of company stock valued at $43,736,754 in the last 90 days. Corporate insiders own 14.20% of the company’s stock.
TriMas Stock Performance
TriMas (NASDAQ:TRS – Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.03. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The firm had revenue of $241.67 million for the quarter, compared to analysts’ expectations of $235.41 million. During the same quarter last year, the firm posted $0.37 EPS. The company’s revenue was up 6.4% compared to the same quarter last year. Research analysts forecast that TriMas Co. will post 1.69 EPS for the current fiscal year.
TriMas Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th were issued a $0.04 dividend. The ex-dividend date was Tuesday, May 6th. This represents a $0.16 annualized dividend and a dividend yield of 0.61%. TriMas’s payout ratio is currently 20.78%.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on TRS shares. BWS Financial reaffirmed a “buy” rating and set a $40.00 price target on shares of TriMas in a research report on Wednesday, April 30th. Wall Street Zen cut TriMas from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th.
Read Our Latest Stock Report on TriMas
About TriMas
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Articles
- Five stocks we like better than TriMas
- How to Effectively Use the MarketBeat Ratings Screener
- Nike’s Amazon Expansion Could Signal a Turnaround in 2025
- What Are the U.K. Market Holidays? How to Invest and Trade
- Intel’s Turnaround May Be the Best Bet No One’s Watching
- How to find penny stocks to invest and trade
- 3 Defense Stocks That Will Profit From a Golden Dome
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.